檢索結果 - Jui‐Shan Lin
- Showing 1 - 2 results of 2
-
1
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study 由 Keng‐Chang Tsai, Yi-Chia Huang, Chia‐Ching Liaw, Chia-I Tsai, Chun-Tang Chiou, Chien-Jung Lin, Wen-Chi Wei, Jui‐Shan Lin, Yu-Hwei Tseng, Kuo-Ming Yeh, Yi‐Ling Lin, Jia-Tsrong Jan, Jian-Jong Liang, Chun‐Che Liao, Wen-Fei Chiou, Yao‐Haur Kuo, Shen-Ming Lee, Ming-Yung Lee, Yi‐Chang Su
出版 2020Artigo -
2
Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis 由 Yu-Hwei Tseng, Jui‐Shan Lin, Sheng‐Mou Hou, Chih‐Hung Wang, Shun-Ping Cheng, Kung-Yen Tseng, Ming‐Yung Lee, Shen‐Ming Lee, Yi-Chia Huang, Chien‐Jung Lin, Chi-Kuei Lin, Tsung-Lung Tsai, Chen-Shien Lin, Ming‐Huei Cheng, Tieng-Siong Fong, Chia-I Tsai, Yu-Wen Lu, Jung-Chih Lin, Yi-Wen Huang, Wei-Chen Hsu, Hsien-Hwa Kuo, Li-Hsiang Wang, Chia‐Ching Liaw, Wen‐Chi Wei, Keng-Chang Tsai, Yuh‐Chiang Shen, Wen-Fei Chiou, Jaung‐Geng Lin, Yi‐Chang Su
出版 2022Artigo
相關主題
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Intensive care medicine
Internal medicine
Medicine
Outbreak
Virology
2019-20 coronavirus outbreak
Adverse effect
Alternative medicine
Bench to bedside
Clinical endpoint
Clinical trial
Confidence interval
Emergency medicine
Intensive care
Intensive care unit
Intubation
Medical physics
Oxygen therapy
Pandemic
Pathology
Pharmacology
Propensity score matching
Relative risk
Retrospective cohort study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Severity of illness
Subgroup analysis